Recombinant live-attenuated parainfluenza virus type 1 vaccine

parainfluenza virus type 1 vaccine, recombinant, live-attenuated · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant live-attenuated parainfluenza virus type 1 vaccine, covering 2013-02-25 to 2013-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine [Phase 1]

See pricing